Mithramycin Dk置于ketoreductase Mtmw体系中,化学反应生成光辉霉素 参考文献:Molecular Insight Into Substrate Recognition And Catalysis Of Baeyer-villiger Monooxygenase Mtmoiv,The Key Frame-Modifying Enzyme In The Biosynthesis Of Anticancer Agent Mithramycin 标题:Molecular Insight Into Substrate Recognition And Catalysis Of Baeyer-villiger Monooxygenase Mtmoiv,The Key Frame-Modifying Enzyme In The Biosynthesis Of Anticancer Agent Mithramycin 摘要:Baeyer-Villiger Monooxygenases (Bvmos) Have Been Shown To Play Key Roles For The Biosynthesis Of Important Natural Products. Mtmoiv,A Homodimeric Fad-And Nadph-Dependent Bvmo,Catalyzes The Key Frame-Modifying Steps Of The Mithramycin Biosynthetic Pathway,Including An Oxidative C-C Bond Cleavage,By Converting Its Natural Substrate Premithramycin B Into Mithramycin Dk,The Immediate Precursor Of Mithramycin. The Drastically Improved Protein Structure Of Mtmoiv Along With The High-Resolution Structure Of Mtmoiv In Complex With Its Natural Substrate Premithramycin B Are Reported Here,Revealing Previously Undetected Key Residues That Are Important For Substrate Recognition And Catalysis. Kinetic Analyses Of Selected Mutants Allowed Us To Probe The Substrate Binding Pocket Of Mtmoiv And Also To Discover The Putative Nadph Binding Site. This Is The First Substrate-Bound Structure Of Mtmoiv Providing New Insights Into Substrate Recognition And Catalysis,Which Paves The Way For The Future Design Of A Tailored Enzyme For The Chemo-Enzymatic Preparation Of Novel Mithramycin Analogues. Doi:10.1021/cb400399B
专利号:US-2004242897-A1 优先权日:2002-07-31 标题 :Universal support media for synthesis of oligomeric compounds 发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH 摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.
专利号:US-2012177593-A1 优先权日:2009-07-20 标 题 :Synthesis of dendrimer conjugates 发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH 权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN 摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.
专利号:WO-2004011474-A1 优先权日:2002-07-31 标题:Universal support media for synthesis of oligomeric compounds 发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K 权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K 摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.
专利号:US-6653468-B1 优先权日:2002-07-31 标 题 :Universal support media for synthesis of oligomeric compounds 发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH 权利人:ISIS PHARMACEUTICALS INC 摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.
专利号:US-10925977-B2 优先权日:2006-10-05 标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications 发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S 权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS 摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.
专利号:US-10973847-B2 优先权日:2017-06-30 标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof 发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.
1: Portugal J. Mithramycin and its analogs: Molecular features and antitumor action. Pharmacol Ther. 2024 Aug;260:108672. doi: 10.1016/j.pharmthera.2024.108672. Epub 2024 Jun 3. 10(14):eadm7098. doi: 10.1126/sciadv.adm7098. Epub 2024 Apr 3. 3: El-Mayet FS, Santos VC, Wijesekera N, Lubbers S, Harrison KS, Sadeghi H, Jones C. Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic Mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replication. Antiviral Res. 2024 May;225:105870. doi: 10.1016/j.antiviral.2024.105870. Epub 2024 Mar 29. 4: Cao C, Xu Q, Zhu Z, Xu M, Wei Y, Lin S, Cheng S, Zhi W, Hong P, Huang X, Lin D, Cao G, Meng Y, Wu P, Peng T, Wei J, Ding W, Huang X, Sung W, Chen G, Ma D, Li G, Wu P. Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer. Cancer Lett. 2024 Apr 28;588:216809. doi: 10.1016/j.canlet.2024.216809. Epub 2024 Mar 11. 98(1):e0143623. doi: 10.1128/jvi.01436-23. Epub 2023 Dec 12.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198